OBJECTIVE: In the context of an inpatient care provider order entry (CPOE) system, to evaluate the impact of a decision support tool on integration of cardiology "best of care" order sets into clinicians' admission workflow, and on quality measures for the management of acute myocardial infarction (AMI) patients. DESIGN: A before-and-after study of physician orders evaluated (1) per-patient use rates of standardized acute coronary syndrome (ACS) order set and (2) patient-level compliance with two individual recommendations: early aspirin ordering and beta-blocker ordering. MEASUREMENTS: The effectiveness of the intervention was evaluated for (1) all patients with ACS (suspected for AMI at the time of admission) (N = 540) and (2) the subset of the ACS patients with confirmed discharge diagnosis of AMI (n = 180) who comprise the recommended target population who should receive aspirin and/or beta-blockers. Compliance rates for use of the ACS order set, aspirin ordering, and beta-blocker ordering were calculated as the percentages of patients who had each action performed within 24 hours of admission. RESULTS: For all ACS admissions, the decision support tool significantly increased use of the ACS order set (p = 0.009). Use of the ACS order set led, within the first 24 hours of hospitalization, to a significant increase in the number of patients who received aspirin (p = 0.001) and a nonsignificant increase in the number of patients who received beta-blockers (p = 0.07). Results for confirmed AMI cases demonstrated similar increases, but did not reach statistical significance. CONCLUSION: The decision support tool increased optional use of the ACS order set, but room for additional improvement exists.
OBJECTIVE: In the context of an inpatient care provider order entry (CPOE) system, to evaluate the impact of a decision support tool on integration of cardiology "best of care" order sets into clinicians' admission workflow, and on quality measures for the management of acute myocardial infarction (AMI) patients. DESIGN: A before-and-after study of physician orders evaluated (1) per-patient use rates of standardized acute coronary syndrome (ACS) order set and (2) patient-level compliance with two individual recommendations: early aspirin ordering and beta-blocker ordering. MEASUREMENTS: The effectiveness of the intervention was evaluated for (1) all patients with ACS (suspected for AMI at the time of admission) (N = 540) and (2) the subset of the ACS patients with confirmed discharge diagnosis of AMI (n = 180) who comprise the recommended target population who should receive aspirin and/or beta-blockers. Compliance rates for use of the ACS order set, aspirin ordering, and beta-blocker ordering were calculated as the percentages of patients who had each action performed within 24 hours of admission. RESULTS: For all ACS admissions, the decision support tool significantly increased use of the ACS order set (p = 0.009). Use of the ACS order set led, within the first 24 hours of hospitalization, to a significant increase in the number of patients who received aspirin (p = 0.001) and a nonsignificant increase in the number of patients who received beta-blockers (p = 0.07). Results for confirmed AMI cases demonstrated similar increases, but did not reach statistical significance. CONCLUSION: The decision support tool increased optional use of the ACS order set, but room for additional improvement exists.
Authors: Christopher P Cannon; Mary H Hand; Raymond Bahr; William E Boden; Robert Christenson; W Brian Gibler; Kim Eagle; Costas T Lambrew; Thomas H Lee; Bruce MacLeod; Joseph P Ornato; Harry P Selker; Pamela Steele; Robert J Zalenski Journal: Am Heart J Date: 2002-05 Impact factor: 4.749
Authors: Rajendra H Mehta; Cecelia K Montoye; Meg Gallogly; Patricia Baker; Angela Blount; Jessica Faul; Canopy Roychoudhury; Steven Borzak; Susan Fox; Mary Franklin; Marge Freundl; Eva Kline-Rogers; Thomas LaLonde; Michele Orza; Robert Parrish; Martha Satwicz; Mary Jo Smith; Paul Sobotka; Stuart Winston; Arthur A Riba; Kim A Eagle Journal: JAMA Date: 2002-03-13 Impact factor: 56.272
Authors: Javed Butler; Theodore Speroff; Patrick G Arbogast; Martha Newton; Lemuel R Waitman; Renee Stiles; Randolph A Miller; Wayne Ray; Marie R Griffin Journal: Am Heart J Date: 2006-03 Impact factor: 4.749
Authors: G M Chertow; J Lee; G J Kuperman; E Burdick; J Horsky; D L Seger; R Lee; A Mekala; J Song; A L Komaroff; D W Bates Journal: JAMA Date: 2001-12-12 Impact factor: 56.272
Authors: Feliciano B Yu; Nir Menachemi; Eta S Berner; Jeroan J Allison; Norman W Weissman; Thomas K Houston Journal: Am J Med Qual Date: 2009-06-05 Impact factor: 1.852
Authors: Adam Wright; Dean F Sittig; James D Carpenter; Michael A Krall; Justine E Pang; Blackford Middleton Journal: AMIA Annu Symp Proc Date: 2010-11-13
Authors: Kevin Haynes; Darren R Linkin; Neil O Fishman; Warren B Bilker; Brian L Strom; Eric A Pifer; Sean Hennessy Journal: J Am Med Inform Assoc Date: 2011-01-24 Impact factor: 4.497
Authors: Adam Wright; Joshua C Feblowitz; Justine E Pang; James D Carpenter; Michael A Krall; Blackford Middleton; Dean F Sittig Journal: Int J Med Inform Date: 2012-07-18 Impact factor: 4.046